Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Pfizer Inc./Medivation, Inc. tender offer
| August 20, 2016 • Antitrust Risk-shifting • $14 billion |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.